Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Example of Drug Shortage Information and Links
National Resources:
FDA Drug Shortages & Discontinuations
Rpharmy Memorial Drug Shortage Information:
| Drug Products on Critical Shortage | |
| Drug Name | Details |
| dronabinol oral capsules | Supply is critical. Est. release: none. |
| hydroxocobalamin 5g injectable | Available, however manufacturer is unable to guaruntee sterility of 5 g Cyanokit (see letter). Should be administered using a 0.2 micron in-line filter to prevent potential microbial infection. |
| meperidine injectable | Supply is critical. Est. release: Feb 2026 and Jan 2029 |
| methylprednisolone 2 mg tablets | Supply is depleted. Estimated release: Jun 2025 |
| Drug Products on Shortage - Limited Availability | |
| Drug Name | Details |
| alteplase 100 mg vials | Supply is limited. Est. release: None |
| amiodarone injectable (3 mL vials) | Supply is limited. Est release: Jul 2025 |
| erythromycin injectable | Supply is limited. Est. release Oct 2025 |
| hydrocortisone 0.5% cream | Supply is limited. Est release: None |
| hydromorphone injectable | Supply is limited. Est. release: variable, unpredictable, and in small quantities. |
| linezolid injectable in NS | Supply is limited. Est. release: Aug 2025. |
| megestrol 40 mg tablets | Supply is limited. Est. release: Jul 2025. |
| morphine oral solid formulations | Supply is critical on some, limited on others. Est. release: varied, unpredictable, and in small quantities |
| sodium bicarbonate 4.2% injectable | Supply of 10ml syringes is depleted. 10ml vials remain available. Est. release: Sep 2025 |
| sodium bicarbonate 8.4% injectable | Supply of 10ml syringes is depleted. 10ml vials remain available. Est. release: Feb 2026 |
| Relevant Products on National Shortage – No Practice Changes Needed | |
| Drug Name | Details |
| hydrocortisone 100 mg injectable | Supply is adequate to meet needs. |
| lactobacillus acidophilus and bulgaricus granules | Supply is adequate to meet needs. |
| lorazepam injectable | Supply is adequate to meed needs. |
| penicillin G benzathine injectable | Supply is adequate to meet needs. |
| risperidone ODT (oral disentegrating tablet) | Supply is adequate to meed needs. |
| terbutaline injectable | Supply is adequate to meet needs. |
| Discontinued (no longer being manufactured) | |
| Drug Name | Notes/Information |
| lindane products | All presentations have been discontinued FDA Orange Book |
| testosterone transdermal patches | All presentations have been discontinued FDA Orange Book |